Table 2

Results of rebiopsy and association between diagnostic yield and factors

Tissue obtained
Patient characteristicsSuccessFailurep Value
Smoking status
 Squamous cell carcinoma62
Mutational status
Tumour size
 <30 mm2915<0.01
 ≥30 mm596
Rebiopsy site
Previous treatment
  Not received257
 Antiangiogenesis agent
  Not received5913
 Molecular targeting agent
  Not received407
Response of last treatment
  • ALK, anaplastic lymphoma kinase; CR, complete response; EGFR, epidermal growth factor receptor; PD, progressive disease; PR, partial response; SD, stable disease.